Navigation Links
Dr. Esther Babady Discusses the Laboratory and Clinical Benefits of Rapid Blood Culture Diagnostics
Date:6/8/2017

Sepsis is a major cause of morbidity and mortality in hospitalized patients. However, the ability to diagnosis sepsis is challenging and early recognition is a key component in improving outcomes. Currently, blood culture remains the gold standard for diagnosis but identification of bacterial or fungal pathogens using conventional methods is often delayed and results in the institution of empiric antimicrobial therapy. This leaves clinical microbiology laboratories with fewer options for the rapid identification of pathogens from positive blood cultures as methods vary in complexity, turn-around time to results, number of pathogens identified and costs.

This OpGen-sponsored webinar will include a discussion by Dr. Esther Babady, Director of Clinical Microbiology Operations at the Memorial Sloan Kettering Cancer Center, review current options for rapid pathogen identification from positive blood cultures and discuss the presenter’s experience with the use of QuickFISH BC kits and its impact on laboratory workflow and patient outcomes.

Dr. Babady received a doctorate from the Mayo Clinic Graduate School of Biomedical Sciences in biochemistry and molecular biology. She currently serves as the Director of Clinical Operations for the Microbiology Laboratory Service and an Associate attending in the Department of Laboratory Medicine at Memorial Sloan-Kettering Cancer. Her research interests include rapid diagnosis of infections in immunocompromised hosts and the development and evaluation of the clinical utility of molecular microbiology assays.

LabRoots will host the webinar on June 15 at 10:30 a.m. PDT / 1:30 p.m. EDT. To learn more about this event, available continuing education credits or to register, please click here.

About OpGen
OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. Learn more at http://www.opgen.com and follow OpGen on Twitter and LinkedIn.

About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news and science-themed apparel, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at http://www.prweb.com/releases/2017/06/prweb14406069.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. El Segundo, CA Orthodontist, Dr. Esther Feldman, Welcomes Patients to Dr. Smile for Convenient SPEED Braces
2. El Segundo, CA Orthodontist, Dr. Esther Feldman, Offers Convenient Propel Orthodontics at Dr. Smile
3. Orthopedic Surgeon Dr. Steven Meier Discusses the Evolution of Medical Treatments for Chronic Back Issues
4. Thyroid Pharmacist Discusses their Revolutionary Docu-Series “Thyroid Secret”
5. Leading Thyroid expert discusses docu-series “The Thyroid Secret”
6. Author discusses ‘In the Crucible of Chronic Lyme Disease’
7. Prominent Neurosurgeon Discusses Effect to Human Body by Nerve Agents After Kim Jong-nam Assassination
8. Serenity Discusses the Connection Between Drugs and Crime During National Stalking Awareness Month
9. L.A. Oculoplastic Surgeon Dr. Mehryar Taban Discusses Latest Almond Eye Surgery Trend on “The Doctors”
10. Dr. Jonathan Kulbersh Discusses Growing Trend in Plastic Surgery for People Over 65 Years Old
11. Serenity Rehab Observes World AIDS Day and Discusses Link Between Addiction and HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... June 26, 2017 , ... If the devil is in ... red these days. According to recent estimates, 75 – 80% of the medical ... Some studies point to Electronic Health Records (EHR) with automated features designed to ...
(Date:6/25/2017)... CA (PRWEB) , ... June 24, 2017 , ... Create a feel-good lyric music video ... above footage and sound in the timeline and write in the lyrics to any song. ... flying back out. Each line of the text can be added modularly for optimal control. ...
(Date:6/25/2017)... , ... June 25, 2017 , ... With a heatwave currently bearing down on Northern ... out at the pool. Being swimsuit ready is easy with laser hair removal. , ... again can be a burdensome routine when all you want to do is get out, ...
(Date:6/24/2017)... ... June 24, 2017 , ... Dr. ... 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable routine ... visits to the dentist fit into their patients’ busy lifestyles. Dental365 also gladly ...
(Date:6/23/2017)... ... June 23, 2017 , ... "The Better Care Reconciliation ... significant harm to people with all chronic conditions, including mental illnesses, while increasing ... place the Affordable Care Act (ACA) requirement that insurers cover pre-existing conditions, it ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... two Phase 2 trials of its RSV F protein recombinant ... bearing age have been published in the journal ... been shared in prior scientific conferences). The Company previously announced ... 2014. Novavax is developing the RSV F Vaccine with the ...
(Date:6/5/2017)... -- The Cincinnati location of Diplomat ... DPLO), has been awarded a Top Workplaces 2017 ... are based on an employee survey administered by WorkplaceDynamics, LLC, ... The survey measures several aspects of workplace culture, including alignment, ... ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology: